Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients
Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients
Recruiting · NCT07074457 · Registry updated 2025-07-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients | CD30+ Peripheral T-cell Lymphoma | Recruiting | Not applicable | 2025-07-20 | NCT07074457 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The First Affiliated Hospital of Soochow University | 164 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Soochow University | Suzhou | China | 101 |